DOYLESTOWN, Pa., March 20, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncology today announced completion of the first dosing cohort in the Phase I study for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback